These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 300756)
41. Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitro. Rich RR; Abramson SL; Seldin MF; Puck JM; Levy R J Exp Med; 1980 Aug; 152(2 Pt 2):218s-234s. PubMed ID: 6967938 [TBL] [Abstract][Full Text] [Related]
42. Interaction between lymphocytes and inflammatory exudate cells. I. Enhacement of thymocyte response to PHA by product(s) of polymorphonuclear leukocytes and macrophages. Yoshinaga M; Nakamura S; Hayashi H J Immunol; 1975 Aug; 115(2):533-8. PubMed ID: 1080171 [TBL] [Abstract][Full Text] [Related]
43. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA. Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226 [TBL] [Abstract][Full Text] [Related]
44. Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. Britz JS; Askenase PW; Ptak W; Steinman RM; Gershon RK J Exp Med; 1982 May; 155(5):1344-56. PubMed ID: 6461712 [TBL] [Abstract][Full Text] [Related]
45. Ontogeny of antigen-presenting activity of haptenized cells in mice: early development of syngeneic T cell-stimulatory cells in thymus. Hosono M; Katsura Y; Muramatsu S Immunology; 1984 Jan; 51(1):161-8. PubMed ID: 6606616 [TBL] [Abstract][Full Text] [Related]
46. In vitro selection and extended culture of antigen-specific T lymphocytes. II. Mechanisms of selection. Ben-Sasson SZ; Paul WE; Shevach EM; Green I J Immunol; 1975 Dec; 115(6):1723-30. PubMed ID: 52677 [TBL] [Abstract][Full Text] [Related]
47. Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cells. Brown MF; Van M; Abramson SL; Fox EJ; Rich RR J Immunol; 1984 Jan; 132(1):19-24. PubMed ID: 6228578 [TBL] [Abstract][Full Text] [Related]
48. Studies on carrier protein in contact dermatitis: macrophage migration inhibition by soluble epidermal substances as carrier proteins. Miyagawa N; Miyagawa S; Ashizawa T; Sakamoto K; Aodi T Acta Derm Venereol; 1977; 57(1):23-8. PubMed ID: 74164 [TBL] [Abstract][Full Text] [Related]
49. Prevention of tumor growth and enhancement of cell-mediated immunity by an antigen-specific contrasuppressor factor from a T cell hybridoma. Friedman AM; Ptak W; Freedman J; Green DR; Flood PM Prog Clin Biol Res; 1989; 288():281-8. PubMed ID: 2566176 [TBL] [Abstract][Full Text] [Related]
50. The role of macrophages in the production of lymphokines by T and B lymphocytes. Wahl SM; Wilton JM; Rosenstreich DL; Oppenheim JJ J Immunol; 1975 Apr; 114(4):1296-301. PubMed ID: 1090672 [TBL] [Abstract][Full Text] [Related]
51. In vitro studies of contact hypersensitivity. The effect of the haptens 2,4-dinitrochlorobenzene (DNCB) and 2,4-dinitrofluorobenzene (DNFB) and of hapten-protein conjugates on the migration of guinea-pig peritoneal exudate cells. Friend JV; Lane M Immunology; 1973 Nov; 25(5):869-74. PubMed ID: 4761636 [TBL] [Abstract][Full Text] [Related]
52. Alveolar macrophages. V. Comparative studies on the antigen presentation activity of guinea-pig and rat alveolar macrophages. Holt PG; Batty JE Immunology; 1980 Oct; 41(2):361-6. PubMed ID: 6160094 [TBL] [Abstract][Full Text] [Related]
53. Hapten-specific responses to contact sensitizers. Use of fluorodinitrobenzene to elicit migration inhibition and macrophage agglutination factors from lymph node cells of contact-sensitive guinea-pigs. Godfrey HP Immunology; 1976 May; 30(5):685-94. PubMed ID: 58832 [TBL] [Abstract][Full Text] [Related]
54. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population. DeKruyff R; Clayberger C; Cantor H; Dorf ME J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372 [TBL] [Abstract][Full Text] [Related]
55. Human lymphocytes can generate thymus-independent as well as thymus-dependent anti-hapten plaque-forming cell responses in vitro. Golding B; Chang SP; Golding H; Jones RE; Pratt KL; Burger DR; Rittenberg MB J Immunol; 1981 Jul; 127(1):220-4. PubMed ID: 6165766 [TBL] [Abstract][Full Text] [Related]
56. Induction of cell-mediated immunity to chemically modified antigens in guinea pigs. II. The interaction between lipid-conjugated antigens, macrophages, and T lymphocytes. Dailey MO; Post W; Hunter RL J Immunol; 1977 Mar; 118(3):963-70. PubMed ID: 300393 [TBL] [Abstract][Full Text] [Related]
58. Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. IV. Role of macrophage and its soluble factor in antigen-induced MIF production of immune T lymphocytes. Yamamoto Y; Onoue K J Immunol; 1979 Mar; 122(3):942-8. PubMed ID: 376710 [TBL] [Abstract][Full Text] [Related]
59. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system. Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375 [TBL] [Abstract][Full Text] [Related]
60. Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl. Dieli F; Asherson GL; Bonanno CT; Sireci G; Salerno A Immunology; 1995 Mar; 84(3):355-9. PubMed ID: 7751016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]